Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun;169(6):616-24.
doi: 10.1176/appi.ajp.2012.11091365.

Antidepressants may mitigate the effects of prenatal maternal anxiety on infant auditory sensory gating

Affiliations

Antidepressants may mitigate the effects of prenatal maternal anxiety on infant auditory sensory gating

Sharon K Hunter et al. Am J Psychiatry. 2012 Jun.

Abstract

Objective: Prenatal maternal anxiety has detrimental effects on the offspring's neurocognitive development, including impaired attentional function. Antidepressants are commonly used during pregnancy, yet their impact on offspring attention and their interaction with maternal anxiety has not been assessed. The authors used P50 auditory sensory gating, a putative marker of early attentional processes measurable in young infants, to assess the impact of maternal anxiety and antidepressant use.

Method: A total of 242 mother-infant dyads were classified relative to maternal history of anxiety and maternal prenatal antidepressant use. Infant P50 auditory sensory gating was recorded during active sleep at a mean age of 76 days (SD=38).

Results: In the absence of prenatal antidepressant exposure, infants whose mothers had a history of anxiety diagnoses had diminished P50 sensory gating. Prenatal antidepressant exposure mitigated the effect of anxiety. The effect of maternal anxiety was limited to amplitude of response to the second stimulus, while antidepressant exposure had an impact on the amplitude of response to both the first and second stimulus.

Conclusions: Maternal anxiety disorders are associated with less inhibition during infant sensory gating, a performance deficit mitigated by prenatal antidepressant exposure. This effect may be important in considering the risks and benefits of antidepressant use during pregnancy. Cholinergic mechanisms are hypothesized for both anxiety and antidepressant effects, although the cholinergic receptors involved are likely different for anxiety and antidepressant effects.

PubMed Disclaimer

Conflict of interest statement

Dr Ross has equity interest in Johnson and Johnson Pharmaceuticals. Dr. Zerbe has equity interest in Abbott Laboratories, Johnson and Johnson Pharmaceuticals, Merck Pharmaceuticals, and Pfizer. Dr. Zerbe also has a contract with Merck Pharmaceuticals as a statistician in a study of potential benefits of a booster dose of vaccine for varicella zoster.

All other authors report no financial conflicts of interest.

Figures

Figure 1
Figure 1
Individual examples of P50 sensory gating responses during active sleep. Clicks are presented 500 ms apart; the P50 response is noted by hashmarks. The positive P50 peak (hashmark above) was measured relative to the preceding negative trough (hashmark below). (a) An example of intact sensory gating in an infant at 44 weeks post last menstrual period (approximately 4-weeks of age). Note that the response test stimulus (on the right) is suppressed in comparison to the conditioning stimulus (on the left) for a P50 sensory gating ratio of 0.11. (b) An example of an infant also at 44 weeks post last menstrual period (approximately 4-weeks of age) with decreased sensory gating. This infant’s P50 response to the test stimulus (on the right) is similar to that for the conditioning stimulus (on the left), demonstrating lack of response suppression with a sensory gating ratio = 0.94.
Figure 2
Figure 2
Infant P50 ratios (mean ± SD) by group. Group membership is determined by the presence or absence of a maternal history of anxiety disorder and maternal prenatal antidepressant use. There is a significant effect of group membership (F=5.60, ndf=3, ddf=238, p=.001). Infants with a maternal history of an anxiety disorder but without prenatal exposure to antidepressants have P50 ratios significantly elevated compared to each of the other groups. The other groups do not significantly differ from each other. Differences that remain significant after Tukey-Kramer adjustment for multiple comparisons are denoted by an asterisk.
Figure 3
Figure 3
Infant P50 amplitudes in response to the first and second stimuli presented 500 ms apart. Values are means ± standard deviations. For amplitude of P50 response to the first stimulus, the effect of group is not significant (F=1.57, ndf=3, ddf=238, p=.197); however, when groups are collapsed across anxiety status, there is a significant effect of antidepressant exposure (t=2.06, df=240, p=.040). For amplitude of P50 response to the second stimulus, there is a significant effect of group (F=3.83, ndf=3, ddf=.010). For infants without prenatal antidepressant exposure, having a mother with a history of an anxiety disorder is associated with an elevated P50 amplitude in response to the second stimulus, an effect which is at least partially mitigated by prenatal exposure to antidepressants. Differences that remain significant after adjustment for multiple comparisons are denoted by an asterisk.

Comment in

Similar articles

Cited by

References

    1. Alwan S, Reefhuis J, Rasmussen SA, Friedman JM. National Birth Defects Prevention Study. Patterns of Antidepressant Medication Use Among Pregnant Women in a United States Population. The Journal of Clinical Pharmacology. 2011 Feb 1;51(2):264–270. - PubMed
    1. Cohen LS, Altshuler LL, Harlow BL, Nonacs R, Newport DJ, Viguera AC, Suri R, Burt VK, Hendrick V, Reminick AM, Loughead A, Vitonis AF, Stowe ZN. Relapse of Major Depression During Pregnancy in Women Who Maintain or Discontinue Antidepressant Treatment. JAMA: The Journal of the American Medical Association. 2006 Feb 1;295(5):499–507. - PubMed
    1. Yonkers KA, Wisner KL, Stewart DE, Oberlander TF, Dell DL, Stotland N, Ramin S, Chaudron L, Lockwood C. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. General Hospital Psychiatry. 2009;31(5):403–413. - PMC - PubMed
    1. O’Connor TG, Heron J, Golding J, Beveridge M, Glover V. Maternal antenatal anxiety and children’s behavioral/emotional problems at 4 years. Report from the Avon Longitudinal Study of Parents and Children. Br J Psychiatry. 2002;180(502):508. - PubMed
    1. Huizink AC, Dick DM, Sihvola E, Pulkkinnen L, Rose RJ, Kaprio J. Chernobyl exposure as a stressor during pregnancy and behaviour in adolescent offspring. Acta Psychiatr Scand. 2007;116(6):438–446. - PMC - PubMed

Publication types

Substances